Name | 3-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]benzoic acid |
---|---|
Synonyms |
3-[(1-{[(1,1-dimethylethyl)oxy]carbonyl}-4-piperidinyl)methyl]benzoic acid
3-[(1-Boc-4-piperidinyl)methyl]benzoic acid 3-[(1-{[(1,1-dimethyIethyl)oxy]carbonyl}-4-piperidinyl)methyl]benzoic acid 3-((1-(tert-Butoxycarbonyl)piperidin-4-yl)methyl)benzoic acid |
Molecular Formula | C18H25NO4 |
---|---|
Molecular Weight | 319.39500 |
Exact Mass | 319.17800 |
PSA | 66.84000 |
LogP | 3.51230 |
HS Code | 2933399090 |
---|
~% 799283-53-7 |
Literature: AVENTIS PHARMACEUTICALS INC. Patent: WO2004/100946 A1, 2004 ; Location in patent: Page 54 ; WO 2004/100946 A1 |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |